<p>Stem cells have the ability to differentiate into all types of cells within the body, thus have great therapeutic potential for regenerative medicine to treat complicated disorders, like Parkinsonβs disease and spinal cord injury. There will also be many applications in drug development. However,
Engineering and Application of Pluripotent Stem Cells
β Scribed by Ulrich Martin,Robert Zweigerdt,Ina Gruh (eds.)
- Publisher
- Springer International Publishing
- Year
- 2018
- Tongue
- English
- Leaves
- 232
- Series
- Advances in Biochemical Engineering/Biotechnology 163
- Edition
- 1
- Category
- Library
No coin nor oath required. For personal study only.
β¦ Synopsis
βThis book reviews the latest biotechnological advances with pluripotent stem cells, exploring their application in tissue engineering and medicinal chemistry. Chapters from expert contributors cover topics such as the production of transgene-free induced pluripotent stem cells (iPSCs), expansion, controlled differentiation and programming of pluripotent stem cells, and their genetic instability. Particular attention is given to the application of the pluripotent stem cells for vascularision of engineered tissue and for drug screening.
This book will appeal to researchers working in regenerative medicine and drug discovery, and to bioengineers and professionals interested in stem cell research.
β¦ Table of Contents
Front Matter ....Pages i-vii
Nonintegrating Human Somatic Cell Reprogramming Methods (Thorsten M. Schlaeger)....Pages 1-21
Scalable Expansion of Pluripotent Stem Cells (Neta Lavon, Michal Zimerman, Joseph Itskovitz-Eldor)....Pages 23-37
Scalable Cardiac Differentiation of Pluripotent Stem Cells Using Specific Growth Factors and Small Molecules (Henning Kempf, Robert Zweigerdt)....Pages 39-69
Specific Cell (Re-)Programming: Approaches and Perspectives (Frauke Hausburg, Julia Jeannine Jung, Robert David)....Pages 71-115
Bioengineered Cardiac Tissue Based on Human Stem Cells for Clinical Application (Monica Jara Avaca, Ina Gruh)....Pages 117-146
Human Pluripotent Stem Cells to Engineer Blood Vessels (Xin Yi Chan, Morgan B. Elliott, Bria Macklin, Sharon Gerecht)....Pages 147-168
Targeted Gene Editing in Human Pluripotent Stem Cells Using Site-Specific Nucleases (Sylvia Merkert, Ulrich Martin)....Pages 169-186
Acquired Genetic and Epigenetic Variation in Human Pluripotent Stem Cells (O. Kyriakides, J. A. Halliwell, P. W. Andrews)....Pages 187-206
Requirements for Using iPSC-Based Cell Models for Assay Development in Drug Discovery (Klaus Christensen, Filip Roudnicky, Christoph Patsch, Mark Burcin)....Pages 207-220
Back Matter ....Pages 221-228
β¦ Subjects
Biotechnology
π SIMILAR VOLUMES
Pluripotent cells of the early embryo originate all types of somatic cells and germ cells of adult organism. Pluripotent stems cell lines were derived from mammalian embryos and adult tissues using different techniques and from different sources. Despite different origin, all pluripotent stem cell l
<p><p>Human pluripotent stem cells such as human embryonic stem cells (hESC) and induced pluripotent stem cells (iPSC) with their unique developmental plasticity hold immense potential as cellular models for drug discovery and in regenerative medicine as a source for cell replacement. While hESC are
<p><p>Human pluripotent stem cells such as human embryonic stem cells (hESC) and induced pluripotent stem cells (iPSC) with their unique developmental plasticity hold immense potential as cellular models for drug discovery and in regenerative medicine as a source for cell replacement. While hESC are
<p>Induced Pluripotent Stem (iPS) cells are mature cells that have been genetically reprogrammed so that they return to their embryonic state. It is not yet known if iPS stem cells and embryonic stem cells differ significantly. Today many fundamental belief systems in biology are shifting towards ac
<p><p>Almost daily, new technologies are being presented that move the field of human pluripotent stem cell research towards a future that may yield highly-effective, personalized medical treatments. Three enabling technologies at hand for human PSCs are 1) directed reprogramming of somatic cells, w